Trial intelligence / Profile preview

Effect of metformin on kidney and cyst volume in polycystic kidney disease

IRCT2013021912527N1Phase 2Completed

Sponsor
Tehran University of Medical Sciences
Start
Feb 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of metformin in polycystic kidney disease (PKD), sponsored by Tehran University of Medical Sciences. Primary endpoints: Change in kidney volume and Change in cyst volume. Started Feb 2014; status: completed.

02

Drugs

metformin
03

Conditions

polycystic kidney disease (PKD)

Beyond the preview

Go deeper on IRCT2013021912527N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2013021912527N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call